UNSPSC 51384103: Butibufen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H20O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JSS1TEM917, chemically known as butyric acid, 2-(4-isobutylphenyl)- but generally known as butibufen, which bears US NIH Compound Identifier 41643. European Medicines Agency schedules Butibufen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06015MIG.

UNSPSC 51384103 Butibufen is a Commodity code that in recent state and local procurement activity covers the purchase of naloxone and drug deactivation systems for community health and emergency response programs. State and local governments procure these items through straightforward IFB processes to support opioid overdose response and substance abuse mitigation. Issuing bodies include county health departments and community health agencies; Seminole County, Florida, represents the visible recent buyer in this space, seeking naloxone and safe drug deactivation systems through competitive sealed bidding.

Seminole County, Florida, posted IFB 60459723LAS on June 30, 2026, for the annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid response deadline was July 26, 2023 (note: date discrepancy in source), with vendors required to include all shipping and delivery costs in their proposals, provide unit costs for each line item, and comply with E-Verify, drug-free workplace certification, and standard insurance coverage requirements. The contract was structured for an initial two-year term with a one-year renewal option and included a three-month probationary termination clause; the procurement flagged potential FEMA funding and associated federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.